Congresul Național al Federației Societăților Române de Cancer

ZIUA a-1-a / 4 OCTOMBRIE

14:00 - 16:00 - The resident doctor afternoon - Prof. Dr. Rodica Anghel - Prof. Dr. Viorica Nagy 16:00 – 16:30 – Coffee break 16:30 – 18:00 – The resident doctor afternoon Prof. Dr. Rodica Anghel Prof. Dr. Viorica Nagy 18:00 – 20:00 - SRR assembly - SRROM assembly

ZIUA a-2-a / 5 OCTOMBRIE

08:30 – 09:00 – Opening Ceremony 09:00 – 10:30 – Presidential symposium Chair : Prof. Dr . Rodica Anghel, Dr. Mircea Dediu 09:00 – 09:45 – Inside the immune oncology science – Prof.Dr. Jean Pierre Armand 09:45 – 10:30 – How to sequence the available treatments in metastatic melanoma – Prof. Dirk Schadendorf 10:30 – 11:00 – Sarcomas Orphan Disease - Heterogenous Sub-Entities - Heterogenous Treatments : Prof. Dr. Thomas Brodowicz 11:00 – 11:30 – Coffee break 11:30 – 12:30 – Debate : metastatic RAS wt, right side colon cancer : two perspectives on the best treatment sequence Chair : Conf. Dr. Adina Croitoru Antiangiogenics : Dr. Razvan Curca Anti EGFR – Conf. Dr. Adina Croitoru 12:30 – 13:30 – Early breast cancer diagnosis and radiation therapy procedures RT : Conf . Dr. Laura Rebegea - Minimally invasive procedures in pretherapeutical evaluation and treatment in breast cancer - Dr. Lisencu Carmen 13:30 – 14:30 – Lunch 14:30 – 15:30 Find and aim the target in non small cell lung cancer

Chair: Prof. Tudor Ciuleanu

Speaker: Prof. Lucian Miron, Prof. Tudor Ciuleanu, Dr. Mircea Dediu

ZIUA a-3-a / 6 OCTOMBRIE

08:00 - 09:00 > Selected oral presentations Chair: Conf. dr. Laurentia Gales 09:00 - 10:30 > Presidential symposium Chair: Prof. Dr. Michael Untch - 09:00 - 09:45 > Lung cancer : tradition vs innovation : where do we stand ? – Prof. Dr. Tudor Ciuleanu 10:30 - 11:00 > Coffee break 11:00 - 13:00 > Debate Session Chair: Dr. Mircea Dediu - 11:00 - 12:00 > Is pathologic complete remission a reliable endpoint for efficacy in neoadjuvant trials performed in breast cancer ? - Speaker in favor : Prof. Michael Untch - Speaker against : Dr. Mircea Dediu - 12:00 - 13:00 > Debate : The benefit exceeds harms in breast cancer screening - Speaker against : Dr. Mircea Dediu 13:00 - 14:00 > Coffee break 14:00 15:30 > Urogenital cancers : state of the art Chair: Conf. Dr. Gabriel Kacso - Radiation therapy in prostate cancer: does one size fit all ? – Conf. Dr. Gabriel Kacso - Immune therapy - Dr. Lazar Popovic - Renal cancer update - Conf. Dr. Dana Stanculeanu 15:30 - 16:00 > Lunch 16:00 - 17:00 > Innovative systemic approach in gastrointestinal and head and neck tumors Chair: Conf. Dr. Serban Negru - Highlights of immune oncology in gastrointestinal cancer - Conf. Dr. Serban Negru - Innovative approach in systemic treatment in head and neck tumors - Conf. Dr. Laurentia Gales 17:00 - 18:00 > Update in systemic treatment of breast cancer Chair: Conf. Dr. Laurentia Gales - Her 2 positive - Dr. Madalina Draganescu - New trends in the endocrine treatment of advanced breast cancer - Conf. Dr. Laurentia Gales

ZIUA a-4-a / 7 OCTOMBRIE

9.00 - 10.30 - Optimal diagnosis and multimodal approach in Stage III ( N2) NSCLC Chair: Prof. Dr. Rodica Anghel - Diagnosis: Dr Natalia Motas - Radiation therapy: Prof. Dr. Rodica Anghel - Adjuvant vs neoadjuvant chemotherapy in early stage NSCLC : Dr.Mircea Dediu 10:30 - 11:00 > Coffee break 11:00 - 12:00 > The chaos of immune therapy in first line setting of NSCLC Chair: Prof. Dr. Tudor Ciuleanu - Presenting the chaos - Prof. Dr. Tudor Ciuleanu - Attempting to order - Dr. Mircea Dediu 12:00 - 13:00 > Take home messages from the 5th Conference of the Federation Society of Cancer - Dr. Mircea Dediu - Conf. Dr. Calin Cainap

08:00 – 11:00 – Sustinere lucrari

• Comunicarea non-verbală: gesturi , emotii si microexpresii

11:00 – 11:30 - Coffe break

Coffe Break

11:30 – 13:30 – Sustinere lucrari

• Tumori cu indicatie de Radioterapie

13:30 – 14:30 – Pranz

Pranz

14:30 – 17:00 – Sustinere lucrari

• Transformari fundamentale in metabolismul cancerului

17:00 – 17:30 – Coffee break

– Coffee break

17:30 – 19:00 – Sustinere lucrari

• The expression pattern of HOXA11 AS in cervical cancer precursor lesions